BioNTech co-founders Uğur Şahin and Özlem Türeci (Sebastian Gollnow/picture-alliance/dpa/AP Images)
BioNTech’s ‘extensive’ cancer pipeline comes into focus, with emphasis on ADCs
BioNTech, one of the biotech startups that helped vaccinate billions of people around the world against Covid-19, is starting to look like a cancer company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
